After studying this text, it is best to have the ability to:
Perimenopause is a transitional state describing the interval previous menopause, with accompanying endocrinological, organic and medical options[1–3]. The phrases ‘perimenopause’ and ‘menopausal transition’ can be utilized interchangeably. Menopause, though generally used to explain perimenopause, is characterised by 12 consecutive months of amenorrhoea, marking reproductive senescence[4–6].
In England and Wales, 51% of the inhabitants are ladies. A current name for proof for the first-ever government-led Girls’s Well being Technique for England recognized a necessity for schooling and coaching of healthcare professionals in ladies’s well being, particularly menopause and hormone substitute remedy (HRT). The analysis report discovered that signs related to menopause weren’t at all times recognised or taken critically, with some GPs reluctant to prescribe HRT.
Within the UK, the typical age of menopause is 51 years. Though the median length of perimenopause is 4 years, it might happen for greater than a decade previous menopause. Perimenopause might be extra symptomatic and harder to deal with than post-menopause, considerably impacting affected ladies’s high quality of life[2,10]. As many as 85% of ladies expertise bodily and/or psychological signs throughout perimenopause. Signs and severity can range, and virtually 90% of those ladies will search recommendation on symptom administration from healthcare professionals[3,12,13].
Pharmacists should undertake an evidence-based strategy to managing signs of perimenopause: recognising and managing signs, explaining the advantages and dangers of remedy, and referring as and when required.
The menstrual cycle
There are two phases of the menstrual cycle: the follicular (proliferative) section and the luteal (secretory) section. The median length of a menstrual cycle is 28 days, with most cycles starting from 25 days to 30 days. This variability in cycle size is predominantly owing to various lengths of the follicular section (i.e. 10–16 days); the luteal section tends to be comparatively steady.
Hormones produced within the pituitary gland — luteinising hormone and follicle-stimulating hormone — regulate the menstrual cycle. Collectively, luteinising hormone and follicle-stimulating hormone promote ovarian follicle development, ovulation and ovarian manufacturing of oestrogen and progesterone. Oestrogen and progesterone prime the uterus for potential endometrial blastocyst implantation[15,16].
Physiology of perimenopause
Perimenopause is conventionally divided into early and late phases (see ‘Diagnosis’ under). Endocrine adjustments throughout perimenopause are primarily liable for the related physiological adjustments[17,18]. A decline within the variety of ovarian follicles leads to a lower within the ranges of inhibin B, anti-Mullerian hormone and ovarian oestradiol[17,19]. Declining oestrogen ranges are in all probability liable for the vasomotor signs (e.g. scorching flushes) related to late perimenopause and the following failure of endometrial growth leads to irregular menstrual cycles. Importantly, the decline in oestrogen throughout perimenopause shouldn’t be regular: oestrogen ranges fluctuate extensively, virtually each day[20–22].
Menopause and related amenorrhoea outcome from a discount within the variety of ovarian follicles and the following lack of ovarian follicular exercise. As a result of oestrogen and inhibin B have an inhibitory impact on gonadotrophins, the manufacturing of follicle-stimulating hormone and luteinising hormone will increase, ovulation doesn’t happen, oestrogen manufacturing is decreased and menstruation ceases[17,19].
After menopause, follicle-stimulating hormone ranges are raised, oestradiol ranges are decreased and inhibin B and anti-Mullerian hormone ranges are undetectable.
Perimenopause is recognized clinically. An intensive historical past, together with menstrual cycle and signs (e.g. vasomotor signs, irregular durations), reasonably than laboratory outcomes, in wholesome ladies aged over 45 years is required. Measurement of reproductive hormone ranges is of little medical profit. Throughout perimenopause, two-fold increased than regular ranges of oestradiol, extraordinarily low ranges of oestradiol and abnormally frequent ovulatory episodes have all been related to irregular cycles[2,9,23]. The Nationwide Institute of Well being and Care Excellence (NICE) has explicitly said that laboratory exams, together with the next, will not be required to diagnose perimenopause in ladies aged over 45 years:
- Anti-Mullerian hormone;
- Inhibin A;
- Inhibin B;
- Antral follicle rely;
- Ovarian quantity;
- Follicle-stimulating hormone.
STRAW+10 staging system
The STRAW+10 staging system, a revision and replace of the ‘Levels of Reproductive Getting old Workshop’ (STRAW) staging system, characterises the reproductive ageing of ladies by to post-menopause (stage –5 by to stage +2). In keeping with STRAW+10, perimenopause covers early menopausal transition (stage –2), late menopausal transition (stage –1) and the primary (stage +1a) of the three phases (+1a, +1b, +1c) of early post-menopause.
In STRAW+10, the length of ‘early’ menopausal transition (stage –2) is variable, with the principal standards of ‘variable’ menstrual cycle size and a ≥7-day distinction in size of ‘consecutive’ menstrual cycles. No signs (e.g. vasomotor signs) are listed for descriptive traits in early perimenopause. Listed supportive standards are: variable and elevated follicle-stimulating hormone, low anti-Mullerian hormone and low inhibin B ranges.
The length of late menopausal transition (stage –1) is 1–3 years, with the first criterion of ≥60 days of amenorrhoea throughout the menstrual cycle. Vasomotor signs are listed as descriptive traits with the next supportive standards: elevated follicle-stimulating hormone (>25 IU/L), low anti-Mullerian hormone, and low inhibin B.
For the primary (stage +1a) of the three phases of post-menopause (phases +1a, +1b, +1c), which can be the final of the three phases of perimenopause, vasomotor signs are listed as ‘most’ seemingly.
There isn’t any uniform expertise of perimenopause. Signs, symptom severity, menstrual cycle and menstrual movement range considerably between ladies. Ethnic, cultural, spiritual, private, sociological and dietary standing can have an effect on each the depth and the incidence of signs[2,25,26].
A current multinational research (UK, Europe, Australia) discovered that extra UK ladies skilled signs than ladies in every other European nation. Signs, generally, had been discovered to doubtlessly have substantial adverse results on high quality of life.
Girls usually expertise extra signs throughout perimenopause than post-menopause, probably owing to erratic hormonal fluctuations[2,27]. Erratic will increase in oestradiol and inconsistent ranges of progesterone are in all probability liable for signs of each oestrogen extra (e.g. complications, migraines, breast tenderness, menstrual flooding) and oestrogen deficiency (e.g. vaginal dryness, vasomotor signs). Different signs embrace, however will not be restricted to, sleep and temper issues, anxiousness, fatigue, arthralgia and gastrointestinal signs[2,28].
Girls who expertise early-onset perimenopause (i.e. earlier than the median age of 47 years) and cycle irregularity usually tend to be symptomatic, and expertise an extended perimenopausal interval, in contrast with ladies with later-onset perimenopause. Extra variable hormone ranges over time are additionally related to extra signs. Additional, physique mass index (BMI) and race could have an effect on hormone ranges. An affiliation between weight problems and decrease ranges of luteinising hormone, follicle-stimulating hormone, oestradiol and progesterone, along with decreases in urinary hormone metabolite excretion, have been discovered. And, in a single research, African American and Hispanic ladies had increased ranges of follicle-stimulating hormone and testosterone, in contrast with different ethnic teams. Signs related to perimenopause might be indicative of different pathologies, so administration of perimenopausal signs ought to contain the exclusion of differential diagnoses.
Menstrual movement and cyclicity
Throughout perimenopause, it may be troublesome to differentiate regular menstrual bleeding from irregular menstrual bleeding, due to variations in bleeding patterns between ladies. There generally is a huge variation in menstrual movement and cyclicity owing to ‘erratic’ peaks of oestradiol and inconsistent luteal section ranges of progesterone. Menstrual cycles will not be at all times longer: in early perimenopause, outlined by STRAW standards stage –2 (see part on ‘prognosis’, above), brief cycles of <21 days are extra frequent[18,24]. Longer cycles of >36 days are extra frequent in late perimenopause (STRAW standards stage –1)[18,24]. Elevated reasonably than decreased size of menstrual bleeding can be extra seemingly: within the SWAN potential cohort research, 77% of ladies reported at the least 3 episodes of bleeding lasting for extra that 10 days.
Complications and migraines
The prevalence of migraine in childhood is identical for each organic sexes. After puberty, the prevalence of migraine in ladies will increase, with prevalence three to 4 instances increased in ladies in contrast with males[34–36]. The impact of hormonal fluctuations on migraine is so pronounced that menstrual migraine is recognised, by worldwide classification, as a definite headache dysfunction.
Perimenopause is related to an elevated susceptibility to migraines[38,39]. Fluctuating oestrogen ranges are in all probability accountable, and progesterone’s attenuation of ache responses could additional compound this. A number of research have indicated that migraines throughout perimenopause are longer, extra extreme, have extra related signs and are much less aware of acute medicine in contrast with non-menstrual migraines[40–43]. Though perimenopausal migraine shouldn’t be recognised as an unbiased medical situation; therapy choices for menstrual migraine and perimenopausal migraine comply with the identical rules.
Hormone fluctuations throughout perimenopause could cause psychiatric signs. Perimenopause has been related to temper issues (e.g. depressive issues, bipolar dysfunction) and, though first onset is multifactorial throughout perimenopause, it’s influenced by hormonal fluctuations, particularly oestrogen. Oestrogen acts as a serotonergic agonist and modulator, rising synthesis and uptake[45,46]. Fluctuating ranges of each oestrogen and progesterone have an effect on the serotonin and neuronal networks and due to this fact temper. Depressed temper throughout perimenopause, together with new-onset main depressive dysfunction and anxiousness, has been demonstrated in three strong longitudinal research[47–49]. Additional, ladies are two to 4 instances extra prone to expertise main melancholy throughout and instantly after perimenopause, even after controlling for prior historical past of main melancholy, medicine use, vasomotor signs and really life upsetting occasions[47,50].
Sleep issues, bother falling asleep, interrupted sleep and early awakening are quite common throughout perimenopause: 37% of ladies aged 40–55 years have reported issue sleeping[18,51]. Girls with sleep disturbances previous to perimenopause are inclined to have worsening sleep signs all through perimenopause, solely stabilising post-menopause. Though hormone ranges don’t appear to be related to sleep disturbances, there’s a sturdy affiliation with stress, life-style elements, psychological and vasomotor signs. Different circumstances related to perimenopause, reminiscent of melancholy and anxiousness, also can trigger early awakening. Fatigue, one other frequent grievance throughout perimenopause, could also be a results of sleep high quality and variance of sleep.
Oestrogen acts on the cholinergic system, selling neuronal development and neuronal survival. And, though the pre-frontal cortex supporting cognitive operate could also be significantly delicate to oestrogen, cognitive adjustments and severity of those adjustments throughout perimenopause shouldn’t be effectively understood, nor are the consequences of fluctuating hormones on cognition. Many ladies report forgetfulness and difficulties in focus throughout perimenopause. There may be proof to recommend that whereas pre- and post-menopausal ladies demonstrated enhancements with repeated exams for verbal reminiscence and processing pace, perimenopausal ladies didn’t. Nonetheless, different research haven’t constantly proven vital variations in ladies at totally different menopausal phases.
The prevalence of arthralgia in ladies seems to extend throughout perimenopause[30,55]. And, though the incidence of rheumatological illness and joint discomfort will increase with age, there’s an affiliation of joint ache with perimenopause. Joint ache and stiffness have been reported as a few of the extra prevalent and bothersome signs and could also be a results of reducing oestrogen ranges[30,55–61].
Throughout perimenopause, ladies expertise gastrointestinal signs, reminiscent of constipation, diarrhoea, gastro-oesophageal reflux, stomach ache and bloating[62,63]. Research on gastrointestinal signs in ladies at numerous ages assist an affiliation with perimenopause[62,64–66]. Additional, each intestinal operate and transit pace might be affected by ovarian hormones.
Roughly 80% of ladies expertise scorching flushes, or scorching flashes, throughout perimenopause[68–70]. Sizzling flushes normally final for as much as 5 minutes, however can final for as much as an hour. They’ve been described as sudden emotions of heat or warmth, particularly within the higher physique (e.g. face, neck, chest), which can be accompanied by peripheral vasodilatation, profuse sweating and generally adopted by a chill[18,71]. Sizzling flushes are partially mediated by oestrogen depletion throughout late perimenopause. Expertise of scorching flushes appears to be influenced by race and ethnicity, with the very best reported prevalence in white ladies and the bottom in Japanese and Chinese language ladies. Weight problems additionally seems to be an element: a better BMI has been related to worse signs[18,71,72].
Deceasing oestrogen ranges are related to a lower in vaginal collagen, hyaluronic acid and elastin content material, thinned epithelium and elevated vaginal pH. Vaginal dryness, atrophy, dyspareunia and urinary signs, though extra frequent post-menopause, additionally have an effect on ladies throughout perimenopause. Vaginal dryness could cause ache throughout sexual activity, affecting sexual operate and high quality of life. In a single research, 40% of ladies who reported vulvovaginal signs additionally reported sexual dysfunction.
Different signs throughout perimenopause which may be affected by fluctuating hormones embrace: melasma (hyperpigmentation of the pores and skin), mastalgia (breast swelling and tenderness), alopecia (scalp hair loss), formication, myalgia, weight achieve and central adiposity[9,76–80].
A holistic, patient-centred strategy ought to be adopted when managing signs of perimenopause. Earlier than commencing remedy (together with HRT), the advantages and dangers of therapy ought to be defined with consideration to the person lady’s literacy and well being literacy. Girls from socio-economically deprived backgrounds can have decrease literacy ranges and are much less prone to be handled for his or her perimenopausal signs[81,82]. To facilitate well being fairness, pharmacists ought to take care to regulate their language to swimsuit the person affected person. Dangers of HRT might be present in NICE tips and assets from the Medicines and Healthcare merchandise Regulatory Company (see Desk[9,83]).
Symptomatic administration will depend upon the stage of perimenopause and affected person choice. Pharmacists, after a danger–profit evaluation and provision of applicable schooling and counselling, ought to facilitate shared choice making. Larger oestrogen ranges throughout early perimenopause are related to menorrhagia, mastalgia, weight achieve and complications. Vasomotor signs and vaginal dryness extra generally accompany decrease oestrogen ranges throughout late perimenopause. Signs ought to be recurrently monitored and therapy adjusted as required.
HRT and cognitive behavioural remedy (CBT) ought to be thought of to alleviate low or depressed temper. Moreover, CBT ought to be thought of to handle anxiousness. Within the absence of a prognosis of melancholy, there’s presently no proof to assist prescribing selective serotonin-reuptake inhibitors (SSRIs) or serotonin and norepinephrine reuptake inhibitors (SNRIs) to alleviate low temper. Steering is on the market from the British Menopause Society and NICE on alternate options to HRT, together with SSRIs and SNRIs[9,84,85].
For vasomotor signs, HRT with oestrogen and progesterone might be supplied to ladies with a uterus; oestrogen-only HRT can solely be supplied to ladies who’ve had a hysterectomy (or is and not using a uterus). SSRIs, SNRIs and clonidine shouldn’t be supplied first line. The British Menopause Society supplies steerage on prescribing clonidine.
Vaginal oestrogen ought to be supplied together with systemic HRT to alleviate signs; therapy ought to be continued for so long as required. The place systemic HRT is contraindicated, a specialist ought to be consulted and vaginal oestrogen ought to be thought of. Counselling ought to be supplied; antagonistic results from vaginal oestrogen are very uncommon, any unscheduled vaginal bleeding ought to be reported to the GP. Girls must also learn that signs will return on cessation of remedy. For vaginal dryness, moisturisers and lubricants can be utilized alone or along with vaginal oestrogen.
HRT ought to be thought of for altered sexual operate. If HRT alone shouldn’t be efficient, testosterone supplementation might be thought of.
Compounded bioidentical hormones
The efficacy and security of unregulated and compounded bioidentical hormones are unknown. Moreover, the standard, purity and constituents of the merchandise will not be at all times recognized.
There may be some proof that isoflavones or black cohosh could relieve vasomotor signs, however these maintain dangers. As with all natural medicines, totally different preparations can be found and should range. As well as, security is unsure and interactions with different medicines have been reported. Natural medicines will not be as extremely regulated as prescription-only medicines (POM); there’s usually inadequate proof on efficacy and security (e.g. interactions). Whereas ladies could select to make use of complementary medicines alone or along side typical remedy (e.g. HRT), pharmacists ought to clarify dangers, advantages and obtainable or lack of proof to make sure patient-informed administration selections are made.
Though St John’s wort has some proof of profit for the reduction of vasomotor signs, there are doubtlessly severe drug interactions (e.g. tamoxifen, anticoagulants, anticonvulsants) and uncertainty relating to applicable doses and the persistence of results.
Cognitive behavioural remedy
CBT is a short-term, non-pharmacological technique that can be utilized to handle anxiousness, stress, depressed temper, scorching flushes, evening sweats, sleep disturbances and insomnia throughout perimenopause. CBT might be supplied by basic practitioners, counsellors, psychological wellbeing practitioners and skilled nurses[83,86].
Holistic administration of perimenopause contains contraception — which is able to must be continued for two years after menopause in ladies underneath 50 years and for 1 12 months in ladies over 50 years — owing to unpredictable ovulation[2,87].
The mixed oral contraceptive capsule can be used to suppress the menstrual cycle in early perimenopause to handle hormonal fluctuations and/or the signs related to increased oestrogen ranges[2,84]. Mixed oral contraceptive capsules that comprise oestradiol or oestradiol valerate (e.g. Zoely [Theramex]; Qlaira [Bayer]), when taken constantly (i.e. with out medicine-free days), will deal with menorrhagia and mastalgia. A levonorgestrel intrauterine machine or progestogen-only contraceptive capsule will present contraceptive cowl however is not going to deal with mastalgia; it doesn’t sufficiently suppress the menstrual cycle. Throughout late perimenopause, ladies on a levonorgestrel intrauterine machine with signs of oestrogen deficiency might be handled with further oestrogen (e.g. patches).
Hormone substitute remedy
Essentially the most applicable HRT will depend upon the lady’s choice, the signs and stage of perimenopause (signs in early perimenopause are in all probability related to oestrogen extra and in late perimenopause, signs are related to oestrogen deficit), her contraception preferences, profit and danger evaluation, and whether or not she has a uterus (see Determine 1[1,2]).
Remedy (see Field 1 and Desk 2) ought to be reviewed for efficacy and tolerability at three months after graduation and yearly thereafter, until earlier assessment is indicated and referral to a specialist is required. Indications for earlier assessment embrace insufficient therapy response and unacceptable or sudden negative effects. For instance, unscheduled vaginal bleeding is a standard facet impact within the first three months of HRT, however ought to be investigated if it continues or happens past the primary three months. Additional, referral to a specialist ought to be thought of the place HRT is contraindicated or there’s uncertainty relating to essentially the most applicable therapy. Girls with breast most cancers or at excessive danger of breast most cancers ought to be referred. Regularly ceasing HRT could restrict rebound signs within the brief time period however doesn’t seem to have any long-term advantages.
Field 1: Oestrogen-only hormone substitute remedy
Oral oestrogen solely
Oestradiol 1mg or 2mg tablets (Elleste Solo [Mylan]; Zumenon [Mylan]; Progynova [Bayer])
Transdermal oestrogen solely
Oestradiol patches (micrograms per hour) twice weekly:
- Evorel (Theramex, 25, 50, 75 or 100);
- Estradot (Novartis, 25, 50, 75 or 100);
- Estraderm (Mera Labs Luxco II, 25, 50, 75 or 100);
- Femseven mono (Theramex, 50, 75 or 100);
- Progynova TS (Bayer, 50 or 100).
Oestradiol gel (0.75mg per pump actuation)
- Oestrogel 1 pump actuation as soon as every day = Evorel 25 twice weekly;
- Oestrogel 2 pump actuations as soon as every day = Evorel 50 twice weekly.
Oestradiol gel (0.5mg or 1.0mg per sachet)
- Sandrena (Orion Pharma) 0.5 mg gel 1 sachet as soon as every day = Evorel 25 twice weekly;
- Sandrena 1 sachet as soon as every day = Evorel 50 twice weekly.
Oestradiol spray (1.53mg per spray)
- Lenzetto (Gedeon Richter) 3 sprays as soon as every day = Evorel 50 twice weekly
Field 2: Oestrogen plus sequential progestogen hormone substitute remedy
Oestradiol (1mg or 2mg) plus dydrogesterone 10mg oral tablets
- Femoston (Mylan, 1/10 or 2/10) = oestradiol (1mg or 2mg) every day on days 1 to 14, dydrogesterone 10 mg every day on days 15 to twenty-eight
Oestradiol (1mg or 2mg) plus norethisterone 1mg oral tablets
- Novofem (Novo Nordisk) = oestradiol 1mg every day on days 1 to 16, norethisterone 1mg every day on days 17 to twenty-eight;
- Elleste Duet (Mylan, 1mg or 2mg) = oestradiol (1mg or 2mg) every day on days 1 to 16, norethisterone 1mg every day on days 17 to twenty-eight.
Oestradiol (1mg or 2mg) tablets (Elleste Solo, Zumenon, Progynova)
Progestogen (oral or intrauterine)
- Micronised progesterone 100mg oral capsules (Utrogestan [Besins Healthcare]) — 200mg as soon as every day for 12 days a month
- Medroxyprogesterone 10mg oral tablets (Provera [Pfizer]) — 10mg as soon as every day for 12 days a month
- Norethisterone 5mg oral tablets — 5mg as soon as every day for 12 days a month
- Levonorgestrel 20 micrograms per 24 hours intrauterine machine — efficient for five years
Transdermal oestrogen with sequential progestogen (norethisterone)
Oestradiol with norethisterone patches
- Evorel Sequi = Evorel 50 on days 1 to 14 of menstrual cycle plus Evorel Conti on days 15 to twenty-eight of menstrual cycle
Transdermal oestrogen plus progestogen (oral or intrauterine)
- Transdermal oestrogen solely, equal to Evorel 50
Oral or intrauterine progestogen
- Micronised progesterone 100mg oral capsules (Utrogestan) — 200mg as soon as every day for 12 days a month
- Medroxyprogesterone 10mg oral tablets (Provera) — 10mg as soon as every day for 12 days a month
- Norethisterone 5mg oral tablets — 5mg as soon as every day for 12 days a month
- Levonorgestrel 20 micrograms per 24 hours intrauterine machine — efficient for five years.
- Menopause is recognized 12 months after a lady’s final menstrual interval, marking the tip of that lady’s reproductive potential. The typical age of menopause is 51 years.
- Perimenopause can have an effect on ladies for greater than a decade previous menopause;
- Laboratory exams will not be normally required to diagnose perimenopause;
- HRT doesn’t present contraceptive cowl;
- Pharmacists must know when to refer sufferers to different healthcare professionals;
- Girls with a uterus on increased doses of oestrogen could require increased doses of progestogen for uterine safety;
- Estradiol 10 microgram vaginal tablets (GINA) was made obtainable over-the-counter from September 2022 for vaginal atrophy in post-menopausal ladies aged 50 years and above. Pharmacists should concentrate on vaginal-atrophy signs and therapy, and when to refer.
Pharmacists ought to concentrate on and supply schooling on the next info, making certain the knowledge is commensurate with ladies’s literacy and well being literacy:
- An absence of vasomotor signs doesn’t exclude a prognosis of perimenopause;
- Vasomotor signs are seemingly throughout late perimenopause and probably throughout early post-menopause;
- Expertise of vasomotor signs might be influenced by race and ethnicity;
- Signs not at all times or historically related to perimenopause embrace anxiousness, temper issues, shorter menstrual cycle, elevated length of menstrual bleeding, arthralgia, complications and migraine;
- A patient-centred, collaborative and evidence-based strategy to symptom administration is required;
- Advantages and dangers of therapy ought to be assessed and defined to ladies with consideration to their literacy and well being literacy;
- Pharmacists ought to at all times facilitate shared decision-making to permit for finest therapy choices.
Perimenopause can have a big adverse influence on a lady’s high quality of life. A necessity for schooling and coaching of healthcare professionals in ladies’s well being has been recognized by the current name for proof within the first-ever government-led ‘Girls’s Well being Technique for England’. Proof-based medication should be integrated right into a patient-centred, collaborative strategy to administration. Girls should be supported to make knowledgeable choices about their very own therapy; self-determination is a elementary human proper. As one of the crucial accessible healthcare professionals within the UK, pharmacists should have the ability to recognise and assist ladies handle signs of perimenopause, referring when required.
The views and opinions expressed on this article are these of the writer and don’t mirror the place of Society of Hospital Pharmacists of Australia or Australian Well being Practitioner Regulation Company.
3Santoro N. Perimenopause: From Analysis to Follow. Journal of Girls’s Well being. 2016;25:332–9. doi:10.1089/jwh.2015.5556
5Bacon JL. The Menopausal Transition. Obstetrics and Gynecology Clinics of North America. 2017;44:285–96. doi:10.1016/j.ogc.2017.02.008
6Santoro N, Roeca C, Peters BA, et al. The Menopause Transition: Indicators, Signs, and Administration Choices. The Journal of Medical Endocrinology & Metabolism. 2020;106:1–15. doi:10.1210/clinem/dgaa764
10Fuh J ‐L., Wang S ‐J., Lee S ‐J., et al. High quality of Life Analysis. 2003;12:53–61. doi:10.1023/a:1022074602928
11Talaulikar V. Menopause transition: Physiology and signs. Greatest Follow & Analysis Medical Obstetrics & Gynaecology. 2022;81:3–7. doi:10.1016/j.bpobgyn.2022.03.003
13Guthrie JR, Dennerstein L, Taffe JR, et al. Well being care-seeking for menopausal issues. Climacteric. 2003;6:112–7. doi:10.1080/cmt.188.8.131.52
17Burger HG, Hale GE, Robertson DM, et al. A assessment of hormonal adjustments throughout the menopausal transition: give attention to findings from the Melbourne Girls’s Midlife Well being Venture. Human Copy Replace. 2007;13:559–65. doi:10.1093/humupd/dmm020
18DELAMATER L, SANTORO N. Administration of the Perimenopause. Medical Obstetrics & Gynecology. 2018;61:419–32. doi:10.1097/grf.0000000000000389
20Santoro N, Brown JR, Adel T, et al. Characterization of reproductive hormonal dynamics within the perimenopause. The Journal of Medical Endocrinology & Metabolism. 1996;81:1495–501. doi:10.1210/jcem.81.4.8636357
21Shideler SE, DeVane GW, Kalra PS, et al. Ovarian-pituitary hormone interactions throughout the perimenopause. Maturitas. 1989;11:331–9. doi:10.1016/0378-5122(89)90029-7
22Weber MT, Maki PM, McDermott MP. Cognition and temper in perimenopause: A scientific assessment and meta-analysis. The Journal of Steroid Biochemistry and Molecular Biology. 2014;142:90–8. doi:10.1016/j.jsbmb.2013.06.001
23Hale GE, Hughes CL, Burger HG, et al. Atypical estradiol secretion and ovulation patterns brought on by luteal out-of-phase (LOOP) occasions underlying irregular ovulatory menstrual cycles within the menopausal transition. Menopause. 2009;16:50–9. doi:10.1097/gme.0b013e31817ee0c2
24Harlow SD, Gass M, Corridor JE, et al. Government abstract of the Levels of Reproductive Getting old Workshop + 10. Menopause. 2012;19:387–95. doi:10.1097/gme.0b013e31824d8f40
26Panay N, Palacios S, Davison S, et al. Girls’s notion of the menopause transition: a multinational, potential, community-based survey. GREM 2021;2:178–83. doi:10.53260/grem.212037
29Paramsothy P, Harlow SD, Nan B, et al. Length of the menopausal transition is longer in ladies with younger age at onset: the multiethnic Examine of Girls’s Well being Throughout the Nation. Menopause. 2017;24:142–9. doi:10.1097/gme.0000000000000736
30Freeman EW, Sammel MD, Lin H, et al. Signs Related With Menopausal Transition and Reproductive Hormones in Midlife Girls. Obstetrics & Gynecology. 2007;110:230–40. doi:10.1097/01.aog.0000270153.59102.40
31Santoro N, Lasley B, McConnell D, et al. Physique Measurement and Ethnicity Are Related to Menstrual Cycle Alterations in Girls within the Early Menopausal Transition: The Examine of Girls’s Well being throughout the Nation (SWAN) Every day Hormone Examine. The Journal of Medical Endocrinology & Metabolism. 2004;89:2622–31. doi:10.1210/jc.2003-031578
32Paramsothy P, Harlow S, Greendale G, et al. Bleeding patterns throughout the menopausal transition within the multi-ethnic Examine of Girls’s Well being Throughout the Nation (SWAN): a potential cohort research. BJOG: Int J Obstet Gy. 2014;121:1564–73. doi:10.1111/1471-0528.12768
33Ornello R, De Matteis E, Di Felice C, et al. Acute and Preventive Administration of Migraine throughout Menstruation and Menopause. JCM. 2021;10:2263. doi:10.3390/jcm10112263
34Stovner LJ, Nichols E, Steiner TJ, et al. International, regional, and nationwide burden of migraine and tension-type headache, 1990–2016: a scientific evaluation for the International Burden of Illness Examine 2016. The Lancet Neurology. 2018;17:954–76. doi:10.1016/s1474-4422(18)30322-3
36Steiner TJ, Stovner LJ, et al. Migraine stays second among the many world’s causes of incapacity, and first amongst younger ladies: findings from GBD2019. J Headache Ache. 2020;21. doi:10.1186/s10194-020-01208-0
37Headache Classification Committee of the Worldwide Headache Society (IHS) The Worldwide Classification of Headache Problems, third version. Cephalalgia. 2018;38:1–211. doi:10.1177/0333102417738202
38Martin VT, Pavlovic J, Fanning KM, et al. Perimenopause and Menopause Are Related With Excessive Frequency Headache in Girls With Migraine: Outcomes of the American Migraine Prevalence and Prevention Examine. Headache: The Journal of Head and Face Ache. 2016;56:292–305. doi:10.1111/head.12763
40Granella F, Sances G, Allais G, et al. Traits of Menstrual and Nonmenstrual Assaults in Girls with Menstrually Associated Migraine Referred to Headache Centres. Cephalalgia. 2004;24:707–16. doi:10.1111/j.1468-2982.2004.00741.x
41MacGregor EA, Victor TW, Hu X, et al. Traits of Menstrual vs Nonmenstrual Migraine: A Publish Hoc, Inside-Lady Evaluation of the Common-Care Section of a Nonrandomized Menstrual Migraine Medical Trial. Headache: The Journal of Head and Face Ache. 2010;50:528–38. doi:10.1111/j.1526-4610.2010.01625.x
42Vetvik KG, Benth JŠ, MacGregor EA, et al. Menstrual versus non-menstrual assaults of migraine with out aura in ladies with and with out menstrual migraine. Cephalalgia. 2015;35:1261–8. doi:10.1177/0333102415575723
43Güven B, Güven H, Çomoğlu S. Medical traits of menstrually associated and non-menstrual migraine. Acta Neurol Belg. 2017;117:671–6. doi:10.1007/s13760-017-0802-y
44Musial N, Ali Z, Grbevski J, et al. Perimenopause and First-Onset Temper Problems: A Nearer Look. FOC. 2021;19:330–7. doi:10.1176/appi.focus.20200041
46Kugaya A, Epperson CN, Zoghbi S, et al. Enhance in Prefrontal Cortex Serotonin2AReceptors Following Estrogen Remedy in Postmenopausal Girls. AJP. 2003;160:1522–4. doi:10.1176/appi.ajp.160.8.1522
47Bromberger JT, Kravitz HM. Temper and Menopause: Findings from the Examine of Girls’s Well being Throughout the Nation (SWAN) over 10 Years. Obstetrics and Gynecology Clinics of North America. 2011;38:609–25. doi:10.1016/j.ogc.2011.05.011
48Cohen LS, Soares CN, Vitonis AF, et al. Threat for New Onset of Despair In the course of the Menopausal Transition. Arch Gen Psychiatry. 2006;63:385. doi:10.1001/archpsyc.63.4.385
49Freeman EW, Sammel MD, Lin H, et al. Associations of Hormones and Menopausal Standing With Depressed Temper in Girls With No Historical past of Despair. Arch Gen Psychiatry. 2006;63:375. doi:10.1001/archpsyc.63.4.375
50Bromberger JT, Kravitz HM, Chang Y-F, et al. Main melancholy throughout and after the menopausal transition: Examine of Girls’s Well being Throughout the Nation (SWAN). Psychol. Med. 2011;41:1879–88. doi:10.1017/s003329171100016x
51Kravitz HM, Joffe H. Sleep In the course of the Perimenopause: A SWAN Story. Obstetrics and Gynecology Clinics of North America. 2011;38:567–86. doi:10.1016/j.ogc.2011.06.002
52Kravitz HM, Janssen I, Bromberger JT, et al. Sleep Trajectories Earlier than and After the Closing Menstrual Interval within the Examine of Girls’s Well being Throughout the Nation (SWAN). Curr Sleep Medication Rep. 2017;3:235–50. doi:10.1007/s40675-017-0084-1
54Greendale GA, Huang M-H, Wight RG, et al. Results of the menopause transition and hormone use on cognitive efficiency in midlife ladies. Neurology. 2009;72:1850–7. doi:10.1212/wnl.0b013e3181a71193
56Delavar MA, Hajiahmadi M. Age at menopause and measuring signs at midlife in a group in Babol, Iran. Menopause. 2011;18:1213–8. doi:10.1097/gme.0b013e31821a7a3a
57Chen R, Yu Q, Xu Okay, et al. [Survey on characteristics of menopause of Chinese women with the age of 40-60 years at gynecological clinic from 14 hospitals]. Zhonghua Fu Chan Ke Za Zhi 2013;48:723–7.https://www.ncbi.nlm.nih.gov/pubmed/24406126
58Woods NF, Mitchell ES. Sleep Signs In the course of the Menopausal Transition and Early Postmenopause: Observations from the Seattle Midlife Girls’s Well being Examine. Sleep. 2010;33:539–49. doi:10.1093/sleep/33.4.539
59Pansini F, Albertazzi P, Bonaccorsi G, et al. The menopausal transition: a dynamic strategy to the pathogenesis of neurovegetative complaints. European Journal of Obstetrics & Gynecology and Reproductive Biology. 1994;57:103–9. doi:10.1016/0028-2243(94)90051-5
60Fuh J-L, Wang S-J, Lu S-R, et al. The kinmen women-health investigation (KIWI): a menopausal research of a inhabitants aged 40–54. Maturitas. 2001;39:117–24. doi:10.1016/s0378-5122(01)00193-1
61Matthews Okay, Wing R, Kuller L, et al. Affect of the perimenopause on cardiovascular danger elements and signs of middle-aged wholesome ladies. Arch Intern Med 1994;154:2349–55.https://www.ncbi.nlm.nih.gov/pubmed/7944857
62Callan N, Mitchell E, Heitkemper M, et al. Constipation and diarrhea throughout the menopause transition and early postmenopause: observations from the Seattle Midlife Girls’s Well being Examine. Menopause 2018;25:615–24. doi:10.1097/GME.0000000000001057
64Infantino M. The prevalence and sample of gastroesophageal reflux signs in perimenopausal and menopausal ladies. J Amer Acad Nurse Practitioners. 2008;20:266–72. doi:10.1111/j.1745-7599.2008.00316.x
65Burger HG, Dudley EC, Hopper JL, et al. Prospectively Measured Ranges of Serum Follicle-Stimulating Hormone, Estradiol, and the Dimeric Inhibins throughout the Menopausal Transition in a Inhabitants-Based mostly Cohort of Women1. The Journal of Medical Endocrinology & Metabolism. 1999;84:4025–30. doi:10.1210/jcem.84.11.6158
66Kamm MA, Farthing MJ, Lennard-Jones JE, et al. Steroid hormone abnormalities in ladies with extreme idiopathic constipation. Intestine. 1991;32:80–4. doi:10.1136/gut.32.1.80
67Meleine M. Gender-related variations in irritable bowel syndrome: Potential mechanisms of intercourse hormones. WJG. 2014;20:6725. doi:10.3748/wjg.v20.i22.6725
68Huang AJ, Grady D, Jacoby VL, et al. Persistent Sizzling Flushes in Older Postmenopausal Girls. Arch Intern Med. 2008;168:840. doi:10.1001/archinte.168.8.840
69Bansal R, Aggarwal N. Menopausal scorching flashes: A concise assessment. J Mid-life Well being. 2019;10:6. doi:10.4103/jmh.jmh_7_19
70Sassarini J, Anderson RA. New pathways within the therapy for menopausal scorching flushes. The Lancet. 2017;389:1775–7. doi:10.1016/s0140-6736(17)30886-3
71Freedman RR. Menopausal scorching flashes: Mechanisms, endocrinology, therapy. The Journal of Steroid Biochemistry and Molecular Biology. 2014;142:115–20. doi:10.1016/j.jsbmb.2013.08.010
72Thurston RC, Sowers MR, Sternfeld B, et al. Beneficial properties in Physique Fats and Vasomotor Symptom Reporting Over the Menopausal Transition: The Examine of Girls’s Well being Throughout the Nation. American Journal of Epidemiology. 2009;170:766–74. doi:10.1093/aje/kwp203
73Kim H-Okay, Kang S-Y, Chung Y-J, et al. The Current Assessment of the Genitourinary Syndrome of Menopause. J Menopausal Med. 2015;21:65. doi:10.6118/jmm.2015.21.2.65
74Avis NE, Colvin A, Karlamangla AS, et al. Change in sexual functioning over the menopausal transition: outcomes from the Examine of Girls’s Well being Throughout the Nation. Menopause. 2017;24:379–90. doi:10.1097/gme.0000000000000770
75Avis NE, Brockwell S, Randolph JF, et al. Longitudinal adjustments in sexual functioning as ladies transition by menopause. Menopause. 2009;16:442–52. doi:10.1097/gme.0b013e3181948dd0
76Hexsel D, Lacerda DA, Cavalcante AS, et al. Epidemiology of melasma in Brazilian sufferers: a multicenter research. Worldwide Journal of Dermatology. 2013;53:440–4. doi:10.1111/j.1365-4632.2012.05748.x
77MAEDA Okay, NAGANUMA M, FUKUDA M, et al. Impact of Pituitary and Ovarian Hormones on Human Melanocytes In Vitro. Pigment Cell Res. 1996;9:204–12. doi:10.1111/j.1600-0749.1996.tb00110.x
78Hale GE, Hitchcock CL, Williams LA, et al. Cyclicity of breast tenderness and night-time vasomotor signs in mid-life ladies: info collected utilizing the Every day Perimenopause Diary. Climacteric. 2003;6:128–39. doi:10.1080/cmt.184.108.40.206
79Mishra GD, Kuh D. Well being signs throughout midlife in relation to menopausal transition: British potential cohort research. BMJ. 2012;344:e402–e402. doi:10.1136/bmj.e402
80Mirmirani P. Hormones and clocks: do they disrupt the locks? Fluctuating estrogen ranges throughout menopausal transition could affect clock genes and set off persistent telogen effluvium. DOJ. 2016;22. doi:10.5070/d3225030937
81Borgonovi F, Pokropek A. The evolution of socio‐financial disparities in literacy abilities from age 15 to age 27 in 20 international locations. British Instructional Res J. 2021;47:1560–86. doi:10.1002/berj.3738
82Hillman S, Shantikumar S, Ridha A, et al. Socioeconomic standing and HRT prescribing: a research of practice-level information in England. Br J Gen Pract. 2020;70:e772–7. doi:10.3399/bjgp20x713045